StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3058% above fair value
$18.55−1.60 (-7.94%)

Close on Nov 20, 2026Market cap $1.79BP/E –Yield –

Fortrea free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Fortrea's free cash flow for the twelve months ending Sep 30, 2026 was $169.00M. For fiscal 2025 it was $88.30M, down 62.8% from the year before. The highest annual figure on record is $237.30M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.30M-62.8%
FY2024Dec 31, 2024$237.30M+85.2%
FY2023Dec 31, 2023$128.10M+352.7%
FY2022Dec 31, 2022$28.30M-80.3%
FY2021Dec 31, 2021$143.30M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$52.50M-34.0%
Q2 FY2026Jun 30, 2026$19.90M+39.2%
Q1 FY2026Mar 31, 2026-$25.00M–
Q4 FY2025Dec 31, 2025$121.60M+499.0%
Q3 FY2025Sep 30, 2025$79.50M–
Q2 FY2025Jun 30, 2025$14.30M-94.6%
Q1 FY2025Mar 31, 2025-$127.10M–
Q4 FY2024Dec 31, 2024$20.30M+125.6%
Q3 FY2024Sep 30, 2024-$10.60M–
Q2 FY2024Jun 30, 2024$262.50M+86.8%
Q1 FY2024Mar 31, 2024-$34.90M–
Q4 FY2023Dec 31, 2023$9.00M+76.5%
Q3 FY2023Sep 30, 2023-$3.20M-105.0%
Q2 FY2023Jun 30, 2023$140.50M–
Q1 FY2023Mar 31, 2023-$18.20M–
Q4 FY2022Dec 31, 2022$5.10M–
Q3 FY2022Sep 30, 2022$63.90M–

More Fortrea figures

See a number that looks wrong?